Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
contrast agent |
| gptkbp:activeIngredient |
gptkb:gadobutrol
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States 2000 |
| gptkbp:ATCCode |
V08CA09
|
| gptkbp:CASNumber |
138071-82-6
|
| gptkbp:chemicalFormula |
C18H31GdN4O9
|
| gptkbp:contraindication |
severe renal impairment
|
| gptkbp:eliminationHalfLife |
1.8 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gadovist
|
| gptkbp:indication |
vascular imaging
CNS imaging breast MRI |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:molecularWeight |
604.72 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
B (AU) |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
dizziness headache allergic reaction |
| gptkbp:usedFor |
magnetic resonance imaging
|
| gptkbp:bfsParent |
gptkb:Bayer_HealthCare
|
| gptkbp:bfsLayer |
6
|